A Study to Test How Well Different Doses of BI 3822971 Are Tolerated by People With Advanced Cancer (Solid Tumours)

BI 3822971OngoingNot yet recruitingPhase 1Open NCT07744152 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT07744152 · Trial Tracker · ComplyRx